The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer.
Omar Nadeem
No relevant relationships to disclose
Anthony E. Mega
No relevant relationships to disclose
Evan T. Keller
No relevant relationships to disclose
Joseph F. Renzulli
No relevant relationships to disclose
Peter J. Quesenberry
No relevant relationships to disclose
Devasis Chatterjee
No relevant relationships to disclose